Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 4.97
(-3.87%)
AUD 4.97
(-3.87%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 11.5 Million | 9.8 Million | 6.45 Million | 3.19 Million | 2.78 Million | 2.64 Million |
| Cost of Revenue | - | 100.51 Thousand | 46.24 Thousand | 15.62 Thousand | 16.99 Thousand | 22.01 Thousand |
| Gross Profit | 11.5 Million | 9.7 Million | 6.41 Million | 3.18 Million | 2.77 Million | 2.62 Million |
| Operating Expenses | 56.3 Million | 36.06 Million | 30.29 Million | 13.49 Million | 9.82 Million | 6.38 Million |
| Selling, General and Administrative Expenses | 10.52 Million | 4.6 Million | 9.06 Million | 3.81 Million | 5.8 Million | 4.27 Million |
| Research and Development Expenses | 45.78 Million | 31.45 Million | 18.89 Million | 9.67 Million | 4.02 Million | 2.11 Million |
| Other Expenses | - | 9.8 Million | 6.45 Million | - | - | - |
| Cost and Expenses | 56.3 Million | 36.16 Million | 30.29 Million | 13.5 Million | 9.84 Million | 6.4 Million |
| Operating Income | -44.8 Million | -36.16 Million | -30.29 Million | -13.5 Million | -9.84 Million | -6.4 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 295.15 Thousand | -9.69 Million | 17.63 Thousand | -3.17 Million | -2.48 Million | -1.3 Million |
| Earnings before Tax | -42.02 Million | -34.29 Million | -23.73 Million | -13.39 Million | -9.44 Million | -4.98 Million |
| Net Income | -42.32 Million | -24.6 Million | -23.75 Million | -10.22 Million | -6.95 Million | -3.68 Million |
| Earnings Per Share Basic | -0.15 | -0.09 | -0.10 | -0.04 | -0.03 | -0.01 |
| Earnings Per Share Diluted | -0.15 | -0.09 | -0.10 | -0.04 | -0.03 | -0.01 |
| Weighted Average Shares Outstanding | 273.15 Million | 260.41 Million | 248.46 Million | 256.92 Million | 256.92 Million | 256.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 273.15 Million | 260.41 Million | 248.46 Million | 256.92 Million | 256.92 Million | 256.92 Million |
| Gross Margin | 1.00 | 0.99 | 0.99 | 1.00 | 0.99 | 0.99 |
| EBIT Margin | -3.88 | -3.68 | -4.68 | -4.22 | -3.52 | -2.42 |
| Profit Margin | -3.68 | -2.51 | -3.68 | -3.20 | -2.49 | -1.39 |
| EBITDA | -44.64 Million | -26.26 Million | -17 Million | -10.29 Million | -7.04 Million | -3.74 Million |
| Earnings Before Tax Margin | -3.89 | -3.69 | -4.69 | -4.23 | -3.53 | -2.42 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 3.04 Million | - | 3.04 Million | 2.7 Million | 2.7 Million | 9.8 Million |
| Cost of Revenue | 101.9 Thousand | 153.06 Thousand | - | 51.15 Thousand | - | 100.51 Thousand |
| Gross Profit | 2.94 Million | -153.06 Thousand | 3.04 Million | 2.65 Million | 2.7 Million | 9.7 Million |
| Operating Expenses | 16.34 Million | 56.15 Million | 16.34 Million | 23.56 Million | 11.8 Million | 36.06 Million |
| Selling, General and Administrative Expenses | 3.3 Million | - | 3.3 Million | 3.85 Million | 1.95 Million | - |
| Research and Development Expenses | 13.03 Million | - | 13.03 Million | 19.7 Million | 9.85 Million | - |
| Other Expenses | - | - | - | - | - | 9.8 Million |
| Cost and Expenses | 16.34 Million | 56.3 Million | 16.34 Million | 23.61 Million | 11.8 Million | 36.16 Million |
| Operating Income | -13.3 Million | -56.3 Million | -13.3 Million | -23.61 Million | -9.09 Million | -36.16 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 95.19 Thousand | -11.21 Million | 95.19 Thousand | -5.31 Million | 52.37 Thousand | -9.69 Million |
| Earnings before Tax | -12.46 Million | -53.53 Million | -12.46 Million | -22.51 Million | -8.54 Million | -34.29 Million |
| Net Income | -12.56 Million | -42.32 Million | -12.56 Million | -17.2 Million | -8.6 Million | -24.6 Million |
| Earnings Per Share Basic | -0.04 | - | -0.04 | -0.07 | -0.03 | - |
| Earnings Per Share Diluted | -0.04 | - | -0.04 | -0.07 | -0.03 | - |
| Weighted Average Shares Outstanding | 284.38 Million | 273.15 Million | 284.38 Million | 262.75 Million | 260.64 Million | 260.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 284.37 Million | 273.15 Million | 284.37 Million | 262.75 Million | 261.93 Million | 260.41 Million |
| Gross Margin | 0.97 | - | 1.00 | 0.98 | 1.00 | 0.99 |
| EBIT Margin | -4.35 | - | -4.35 | -8.70 | -3.35 | - |
| Profit Margin | -4.13 | - | -4.13 | -6.35 | -3.17 | -2.51 |
| EBITDA | -13.25 Million | - | -13.25 Million | -23.56 Million | -9.07 Million | - |
| Earnings Before Tax Margin | -4.37 | - | -4.37 | -8.72 | -3.36 | -3.69 |
SPLIL
DCI
MNTN-WT
GRHI
PRQR
NSA-PA